Market Overview

Perrigo Buys Remaining Stake in Cobrek Pharma for ~$45M

Share:
Related PRGO
Deutsche Bank Boosts Mylan's Price Target On This Scenario
Worst Performing Industries For April 24, 2015
Mylan 'Raises' Perrigo Bid, But Teva Buzz Builds (Investor's Business Daily)

Perrigo Company (Nasdaq: PRGO) today announced that it has signed a definitive merger agreement and has completed the acquisition of Cobrek Pharmaceuticals, Inc. (Cobrek), a privately-held, Chicago, Illinois-based drug development company, for approximately $45 million on a cash free and debt free basis.

Posted-In: News M&A

 

Related Articles (PRGO)

Around the Web, We're Loving...